STAAR SURGICAL CO (STAA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 01-02. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 150M 300M 450M FY10: 51.1M FY11: 55M FY11: 55M FY12: 62.8M FY13: 63.8M FY14: 72.2M FY15: 75M FY16: 77.1M FY17: 82.4M FY18: 90.6M FY19: 124M FY20: 150.2M FY21: 163.5M FY22: 230.5M FY23: 239.4M FY24: 322.4M FY25: 313.9M FY26: 239.4M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Gross Profit Annual

0 90M 180M 270M FY10: 31.3M FY11: 35.1M FY11: 35.1M FY12: 42.4M FY13: 44.3M FY14: 50.3M FY15: 48.8M FY16: 52.7M FY17: 58.4M FY18: 64.3M FY19: 91.5M FY20: 112M FY21: 118.4M FY22: 178.6M FY23: 223.4M FY24: 252.7M FY25: 239.6M FY26: 182.4M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating Income Annual

-105M -70M -35M 0 35M 70M 105M FY10: -4.9M FY11: -2.6M FY11: -2.6M FY12: 2.8M FY13: -1.2M FY14: 700K FY15: -8M FY16: -5.3M FY17: -12.7M FY18: -3.6M FY19: 6.6M FY20: 11.9M FY21: 6.8M FY22: 33.3M FY23: 43.8M FY24: 28.1M FY25: -12.6M FY26: -91.7M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Net Income Annual

-90M -60M -30M 0 30M 60M 90M FY10: -6.2M FY11: 53K FY11: 53K FY12: 1.3M FY13: -1.8M FY14: 398K FY15: -8.4M FY16: -6.5M FY17: -12.1M FY18: -2.1M FY19: 5M FY20: 14M FY21: 5.9M FY22: 27.5M FY22: 27.5M FY23: 39.7M FY23: 39.7M FY24: 21.3M FY24: 21.3M FY25: -20.2M FY26: -80.4M FY10 FY11 FY13 FY15 FY17 FY19 FY21 FY22 FY23 FY24 FY26

Cost of Revenue Annual

0 30M 60M 90M FY10: 19.7M FY11: 19.9M FY11: 19.9M FY12: 20.4M FY13: 19.5M FY14: 21.9M FY15: 26.2M FY16: 24.4M FY17: 24.1M FY18: 26.3M FY19: 32.4M FY20: 38.2M FY21: 45.1M FY22: 51.8M FY23: 61M FY24: 69.8M FY25: 74.3M FY26: 57M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY10: 1.4M FY11: -4.4M FY11: -4.4M FY12: 5.3M FY13: 3.2M FY14: 3.4M FY15: -8M FY16: -2.2M FY17: 1M FY18: 2.9M FY19: 12.8M FY20: 25.8M FY21: 21M FY22: 44M FY23: 35.7M FY24: 14.6M FY25: 15.7M FY26: -34.2M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY10: 874K FY11: -4.7M FY11: -4.7M FY12: 4.4M FY13: 946K FY14: -93K FY15: -12M FY16: -4.2M FY17: -2.2M FY18: 1.8M FY19: 10.5M FY20: 15.7M FY21: 12.5M FY22: 30.3M FY23: 17.6M FY24: -3.6M FY25: -7.7M FY26: -40M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY10: 32.5M FY11: 34.8K FY11: 34.8M FY12: 36.9M FY13: 36.3M FY14: 38.6M FY15: 38.1M FY16: 39.3M FY17: 40.3M FY18: 41M FY19: 45.3M FY20: 46.9M FY21: 48M FY22: 49.5M FY23: 49.4M FY24: 49.4M FY25: 49.1M FY26: 49.6M FY11 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-21.00 -14.00 -7.00 0.00 7.00 14.00 21.00 Q4 '12: 0.03 Q1 '13: 0.03 Q2 '13: 0.00 Q1 '14: -0.04 Q4 '16: -20.14 Q1 '17: -20.28 Q2 '17: -20.29 Q3 '17: -20.29 Q4 '17: -0.29 Q1 '18: -0.14 Q1 '19: 0.02 Q2 '19: 0.08 Q1 '20: 0.12 Q2 '20: 0.16 Q3 '20: 0.18 Q4 '20: 0.30 Q1 '21: 0.27 Q2 '21: 0.16 Q3 '21: 0.19 Q4 '21: 0.12 Q1 '22: 0.22 Q2 '22: 0.42 Q3 '22: 0.46 Q4 '22: 0.56 Q3 '23: 0.76 Q4 '23: 0.79 Q1 '24: 0.65 Q2 '24: 0.51 Q3 '24: 0.40 Q4 '24: 0.43 Q1 '25: 0.31 Q2 '25: 0.34 Q3 '25: 0.44 Q4 '25: -0.41 Q1 '26: -1.44 Q2 '26: -1.93 Q3 '26: -1.95 Q4 '26: -1.62 Q1 '27: -0.42 Q2 '27: 0.08 Q4 '16 Q1 '18 Q3 '20 Q4 '21 Q3 '23 Q4 '24 Q1 '26 Q2 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.